Solid Biosciences Inc. (SLDB) Operating cash flow 2016–2025
Solid Biosciences Inc. (SLDB) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$156.3MFY2025 · since FY2016: -$20.1M → -$156.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$156.3M | -56.3% |
| FY2024 | -$100.0M | -6.2% |
| FY2023 | -$94.2M | +3.9% |
| FY2022 | -$98.0M | -26.0% |
| FY2021 | -$77.8M | -37.4% |
| FY2020 | -$56.6M | +39.0% |
| FY2019 | -$92.7M | -32.1% |
| FY2018 | -$70.2M | -62.4% |
| FY2017 | -$43.2M | -114.8% |
| FY2016 | -$20.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice